Pathstone Holdings’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $401K | Sell |
4,835
-526
| -10% | -$43.6K | ﹤0.01% | 1807 |
|
|
2025
Q1 | $435K | Buy |
5,361
+699
| +15% | +$56.7K | ﹤0.01% | 1775 |
|
|
2024
Q4 | $418K | Buy |
4,662
+118
| +3% | +$10.6K | ﹤0.01% | 1807 |
|
|
2024
Q3 | $449K | Buy |
4,544
+207
| +5% | +$20.5K | ﹤0.01% | 1778 |
|
|
2024
Q2 | $402K | Sell |
4,337
-1,844
| -30% | -$171K | ﹤0.01% | 1800 |
|
|
2024
Q1 | $587K | Buy |
6,181
+1,916
| +45% | +$182K | ﹤0.01% | 1599 |
|
|
2023
Q4 | $381K | Buy |
+4,265
| New | +$381K | ﹤0.01% | 1669 |
|